HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dong Woo Kang Selected Research

phospholipase D1

1/2021Phospholipase D1 is upregulated by vorinostat and confers resistance to vorinostat in glioblastoma.
11/2020Phospholipase D1 inhibition sensitizes glioblastoma to temozolomide and suppresses its tumorigenicity.
12/2017Phospholipase D1 Inhibition Linked to Upregulation of ICAT Blocks Colorectal Cancer Growth Hyperactivated by Wnt/β-Catenin and PI3K/Akt Signaling.
1/2017Phospholipase D1 Acts through Akt/TopBP1 and RB1 to Regulate the E2F1-Dependent Apoptotic Program in Cancer Cells.
7/2015Targeting phospholipase D1 attenuates intestinal tumorigenesis by controlling β-catenin signaling in cancer-initiating cells.
7/2013Phospholipase D1 has a pivotal role in interleukin-1β-driven chronic autoimmune arthritis through regulation of NF-κB, hypoxia-inducible factor 1α, and FoxO3a.
2/2011Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells.
8/2010Platelet derived growth factor increases phospholipase D1 but not phospholipase D2 expression via NFkappaB signaling pathway and enhances invasion of breast cancer cells.
2/2008Phorbol ester up-regulates phospholipase D1 but not phospholipase D2 expression through a PKC/Ras/ERK/NFkappaB-dependent pathway and enhances matrix metalloproteinase-9 secretion in colon cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dong Woo Kang Research Topics

Disease

18Neoplasms (Cancer)
01/2021 - 02/2008
9Carcinogenesis
11/2020 - 02/2008
6Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 02/2008
4Breast Neoplasms (Breast Cancer)
10/2020 - 09/2009
4Colonic Neoplasms (Colon Cancer)
01/2017 - 02/2008
3Alzheimer Disease (Alzheimer's Disease)
01/2022 - 05/2021
3Inflammation (Inflammations)
08/2014 - 08/2010
2Cognitive Dysfunction
01/2022 - 01/2021
2Glioblastoma (Glioblastoma Multiforme)
01/2021 - 11/2020
2Stomach Neoplasms (Stomach Cancer)
01/2016 - 08/2010
2Gastritis
01/2016 - 08/2010
1Dementia (Dementias)
05/2021
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
05/2021
1Brain Neoplasms (Brain Tumor)
01/2021
1Chronic Disease (Chronic Diseases)
08/2019
1Fatigue
08/2019
1Ileus
01/2017
1Anastomotic Leak
01/2017
1Peptic Ulcer (Peptic Ulcers)
01/2016
1Colitis
07/2015
1Carcinoma (Carcinomatosis)
07/2015
1Hypoxia (Hypoxemia)
07/2013
1Rheumatoid Arthritis
07/2013
1Arthritis (Polyarthritis)
07/2013
1Infections
02/2013
1Diabetes Mellitus
02/2013
1Opportunistic Infections (Opportunistic Infection)
02/2013
1Persistent Infection
02/2013
1Actinomycosis
02/2013
1Alcoholism (Alcohol Abuse)
02/2013
1Stomach Ulcer (Gastric Ulcer)
08/2010
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
12/2008

Drug/Important Bio-Agent (IBA)

111-dodecylpyridoxal (PLD)IBA
10/2020 - 02/2008
9phospholipase D1IBA
01/2021 - 02/2008
9Phospholipase DIBA
08/2014 - 02/2008
7CateninsIBA
01/2020 - 01/2011
3Phosphatidic Acids (Phosphatidic Acid)IBA
10/2020 - 01/2011
3phospholipase D2IBA
10/2020 - 02/2008
2Amyloid beta-PeptidesIBA
01/2022 - 11/2021
2Biomarkers (Surrogate Marker)IBA
05/2021 - 12/2017
2MicroRNAs (MicroRNA)IBA
11/2020 - 07/2015
2Protein Kinase CIBA
10/2020 - 02/2008
2rebamipideIBA
01/2016 - 08/2010
2IsoenzymesIBA
08/2010 - 02/2008
2beta CateninIBA
08/2010 - 05/2010
1Amyloid (Amyloid Fibrils)IBA
01/2022
1Biological ProductsIBA
01/2021
1VorinostatFDA Link
01/2021
1Temozolomide (Temodar)FDA LinkGeneric
11/2020
1Histone Deacetylase InhibitorsIBA
10/2020
1Histone Deacetylases (Histone Deacetylase)IBA
10/2020
1KYA1797KIBA
01/2020
1Cytotoxins (Cytolysins)IBA
01/2017
1Anti-Bacterial Agents (Antibiotics)IBA
01/2017
1Adenosine Triphosphate (ATP)IBA
01/2017
1Protective AgentsIBA
01/2016
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
07/2015
1AzoxymethaneIBA
07/2015
1Dextrans (Dextran)FDA Link
07/2015
1CytokinesIBA
07/2013
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
07/2013
1Amoxicillin (Wymox)FDA LinkGeneric
02/2013
1SteroidsIBA
02/2013
1Penicillin G (Benzylpenicillin)FDA LinkGeneric
02/2013
1Pharmaceutical PreparationsIBA
08/2010
1Platelet-Derived Growth FactorIBA
08/2010
1Small Interfering RNA (siRNA)IBA
08/2010
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
08/2010
1triptolideIBA
09/2009
1Insulin-Like Growth Factor Binding Protein 4IBA
12/2008
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
02/2008
1phorbolIBA
02/2008
1Phorbol EstersIBA
02/2008

Therapy/Procedure

6Therapeutics
01/2021 - 01/2011
1Hematopoietic Stem Cell Transplantation
05/2021
1Transplantation
05/2021
1Colectomy
01/2017
1Length of Stay
01/2017
1Oral Hygiene (Dental Hygiene)
02/2013
1Orthognathic Surgical Procedures
02/2013